A Pilot Study of Immune Activation and Rifampin Absorption in HIV-Infected Patients without Tuberculosis Infection: A Short Report.

Christopher VinnardIsabel ManleyBrittney ScottMariana BernuiJoella AdamsSheryl VargheseIsaac ZentnerMichele A Kutzler

Published in: Tuberculosis research and treatment (2017)

Delayed rifampin absorption may be associated with elevated markers of bacterial translocation among HIV-infected individuals naïve to antiretroviral therapy. This trial is registered with NCT01845298.

Keyphrases

antiretroviral therapy
hiv infected patients
hiv infected
hiv aids
human immunodeficiency virus
hiv positive
mycobacterium tuberculosis
study protocol
phase iii
clinical trial
phase ii
pulmonary tuberculosis
emergency department
randomized controlled trial